Lotus Eye Hospital & Institute (BOM:532998) EPS (Basic): ₹0.04 (TTM As of Mar. 2026)


BOM:532998 Lotus Eye Hospital & Institute Ltd BOM:532998
66 GF Score
Price ₹126.05
GF Value ₹91.77
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Lotus Eye Hospital & Institute EPS (Basic)?

Lotus Eye Hospital & Institute BOM:532998 -2.02% 66 EPS (Basic) is ₹0.04 as of Mar. 2026. GuruFocus rates BOM:532998 with a GF Score™ of 66/100 and a GF Value™ of ₹91.77 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Lotus Eye Hospital & Institute's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹-0.15. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.04.

Lotus Eye Hospital & Institute's EPS (Diluted) for the three months ended in Mar. 2026 was ₹-0.15. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.04.

Lotus Eye Hospital & Institute's EPS without NRI for the three months ended in Mar. 2026 was ₹-0.15. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.04.

During the past 12 months, Lotus Eye Hospital & Institute's average EPS without NRIGrowth Rate was -88.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was -72.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was -41.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Lotus Eye Hospital & Institute's highest 3-Year average EPS without NRI Growth Rate was 156.90% per year. The lowest was -72.50% per year. And the median was 10.00% per year.

Lotus Eye Hospital & Institute  (BOM:532998) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Lotus Eye Hospital & Institute EPS (Basic) Related Terms

Lotus Eye Hospital & Institute EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Lotus Eye Hospital & Institute's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Eye Hospital & Institute EPS (Basic) Chart

Lotus Eye Hospital & Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.44 1.96 1.40 0.36 0.04

Lotus Eye Hospital & Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.26 0.06 -0.13 -0.15
BOM:532998
66GF Score
Lotus Eye Hospital & Institute Ltd BOM:532998
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lotus Eye Hospital & Institute EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Lotus Eye Hospital & Institute's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.804-0)/20.100
=0.04

Lotus Eye Hospital & Institute's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-3.195-0)/21.300
=-0.15

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹0.04 mean?
Lotus Eye Hospital & Institute (BOM:532998) has a EPS (Basic) of ₹0.04 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Lotus Eye Hospital & Institute and its competitors.
Is Lotus Eye Hospital & Institute's EPS (Basic) too high?
Lotus Eye Hospital & Institute's current EPS (Basic) is ₹0.04. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's EPS (Basic) compare to HCA and THC?
Lotus Eye Hospital & Institute's EPS (Basic) of ₹0.04 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Lotus Eye Hospital & Institute and its competitors. Lotus Eye Hospital & Institute's current EPS (Basic) is ₹0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹91.77, compared to a current price of ₹126.05 — trading 37.4% above its estimated fair value. The current EPS (Basic) is ₹0.04. Lotus Eye Hospital & Institute's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current EPS (Basic) is ₹0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued. The current stock price of ₹126.05 is trading 37.4% above its estimated GF Value™ of ₹91.77. GuruFocus considers Lotus Eye Hospital & Institute to be Significantly Overvalued.

Key valuation signals for BOM:532998:

  • EPS (Basic): ₹0.04
  • GF Value™: ₹91.77 vs. price of ₹126.05 (37.4% above fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lotus Eye Hospital & Institute Business Description

Other Exchanges LOTUSEYE:India
Address SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
66GF Score

Get the complete analysis for BOM:532998

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹126.05
Price
₹91.77
GF Value